Short answer
Addus HomeCare Corp (ADUS) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $388M (up 7.0% year over year) with net income of $29M.
Q3 2026 key financials · XBRL
- Revenue
- $388M
- +7.0% YoY · +2.7% QoQ
- Net income
- $29M
- +25.1% YoY · +3.6% QoQ
- Operating margin
- 10.3%
- Gross margin
- 32.1%
- EPS (diluted)
- $1.54
- +24.2% YoY · +3.4% QoQ
Source: XBRL data from the Addus HomeCare Corp (ADUS) Q3 2026 10-Q on SEC EDGAR. USD.
Addus HomeCare Corp Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $387.7M, up 7.0% YoY from $362.3M
- Operating margin 10.3% vs 9.1% YoY, gross margin 32.1% vs 32.2%
- Best segment personal care: revenue $301.0M, up 9.2%, operating margin 19.9% vs 18.5%
- Worst segment hospice: operating margin 22.0% vs 27.3%, revenue $69.0M, up 0.2%
- Cash $98.5M, operating cash flow $133.3M, $100.0M revolving debt repayment, AccentCare acquisition anticipated at approximately $275.0M
- Near-term headwinds: caregiver shortages, inflation, elevated interest rates, Medicaid spending reductions, home health payments estimated down 1.3% in 2026
Risk Factors
- New acquisition risk: AccentCare personal care division purchase, approximately $275.0 million, requires regulatory approvals
- Transaction risk: Acquisition may fail or face delays, while transaction costs remain payable regardless of closing
- Integration risk: Unanticipated liabilities, regulatory risks, and expenses could offset anticipated AccentCare benefits
- Operational risk: Management resources diverted to the acquisition, potentially weakening existing operations
- Market risk: Investor concerns about AccentCare could reduce Addus common stock price
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Addus HomeCare Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.